Bauerfeind AG
USPTO PatentsView assignee record - 59 granted patents across 19 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Bauerfeind ranks #5,740 of 49,997 tracked US assignees by granted-patent volume, with 59 patents across 19 technology areas.
- #5,740
- of 49,997 US assignees by volume
- Top 41%
- by Innovation Score (38.4/100)
- 7.8
- avg claims per patent
- +52%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5740 · Foreign Corporation #5,740 · 59 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 59 grants
- UPPER-Q #5,740/49,997
- PHOTO-FINISH Accuvein
- CPC-FOCUS A61F · 19 areas
- INNOV-THIN 38.4/100
- CLAIMS-SPARSE 7.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +52% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Accuvein, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Bauerfeind’s 38.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Bauerfeind
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Accuvein · near
Accuvein · near
38 score
- Bauerfeind · this assignee
Bauerfeind · this assignee
38 score
- Veracode · near
Veracode · near
38 score
- DePuy Mitek · near
DePuy Mitek · near
38 score
- Transmed7 · near
Transmed7 · near
38 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Bauerfeind's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Bauerfeind?
Each dot is one of Bauerfeind’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bauerfeind’s own 7.8 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Bauerfeind's grants concentrate
Bauerfeind AG is a focused PatentsView assignee: 19 CPC subclasses with 45.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (13 grants) versus a trough of 1 in 2018. By volume, Bauerfeind sits between Arris Technology, Inc. and Blueprint Medicines Corporation.
Bauerfeind's three-year grant acceleration
From 2019–2021 to 2022–2024, Bauerfeind AG moved from 26 to 16 grants (0.61x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Bauerfeind's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Arris Technology
Arris Technology, Inc.
59 patents
- Auras Technology
Auras Technology Co., Ltd.
59 patents
- Accuvein
Accuvein, Inc.
59 patents
- Aerin Medical
Aerin Medical Inc.
59 patents
- Baylor Research I…
Baylor Research Institute
59 patents
- BP Exploration Op…
BP Exploration Operating Company Limited
59 patents
- Banjo
Banjo Corporation
59 patents
- Blueprint Medicin…
Blueprint Medicines Corporation
59 patents
- Bauerfeind ◀
Bauerfeind AG
59 patents
What this shows Bauerfeind holds 59 patents at rank #5,739, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Bauerfeind
By rank, the assignees closest to #5,739 in granted patent volume.
- Arris Technology, Inc. #5,735 · 59 patents
- Auras Technology Co., Ltd. #5,736 · 59 patents
- Accuvein, Inc. #5,737 · 59 patents
- Aerin Medical Inc. #5,738 · 59 patents
- Baylor Research Institute #5,740 · 59 patents
- BP Exploration Operating Company Limited #5,741 · 59 patents
- Banjo Corporation #5,742 · 59 patents
- Blueprint Medicines Corporation #5,743 · 59 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Bauerfeind's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Bauerfeind, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Bauerfeind ranks #238 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (38 here).
Similar claim depth
Nearest assignees by average claims per patent (7.8 here).
Bauerfeind's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 6.8% |
| 2016 | 2 | 3.4% |
| 2017 | 4 | 6.8% |
| 2018 | 1 | 1.7% |
| 2019 | 10 | 16.9% |
| 2020 | 13 | 22.0% |
| 2021 | 3 | 5.1% |
| 2022 | 5 | 8.5% |
| 2023 | 8 | 13.6% |
| 2024 | 3 | 5.1% |
| 2025partial year | 6 | 10.2% |
Which technologies does Bauerfeind AG patent most?
Top 15 of 19 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Bauerfeind AG's patent record in context - here's where to go next.
- Bauerfeind AG's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 45.8% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #5,740 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Bauerfeind AG against Arris Technology, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.